Title:
PEPTIDE AS ANTIVIRAL AGENT, AND USES THEREFOR
Document Type and Number:
Japanese Patent JP2022088370
Kind Code:
A
Abstract:
To provide a therapeutic peptide having antiviral activity with a wide range of spectrum to an influenza virus, particularly to a human influenza virus.SOLUTION: A separated peptide includes a sequence selected from tksrfX/xn, tX/xsrfin, twX/xrfin, twfX/xfin, X/xwftfin, wwftfiX/x, wwftX/xia and tksrfdn, where X/x is D-amino acid or L-amino acid. The peptide has anti-influenza properties to a type infecting to animals and birds and a plurality of types of a human influenza virus, and is useful as a pharmaceutical composition for treatment or prevention of influenza virus infection.SELECTED DRAWING: Figure 5
More Like This:
| WO/1991/005795 | STEM CELL FACTOR |
| WO/1998/050566 | IMPROVED CLONING VECTOR CONTAINING MARKER INACTIVATION SYSTEM |
| JP7181874 | ANTIBODY AGAINST SIGNAL-REGULATING PROTEIN-ALPHA AND METHODS OF USE |
Inventors:
MOHAMED RAJIK MOHAMED IBRAHIM
Application Number:
JP2022029519A
Publication Date:
June 14, 2022
Filing Date:
February 28, 2022
Export Citation:
Assignee:
VIRAMATIX SDN BHD
International Classes:
C12N15/63; A61K31/7088; A61K38/02; A61K39/00; A61K39/145; A61K39/395; A61K45/00; A61P31/16; A61P37/04; A61P43/00; C07K7/06; C07K7/08; C07K7/64; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12Q1/70; C40B40/10
Domestic Patent References:
| JP2011522561A | 2011-08-04 | |||
| JP2004535784A | 2004-12-02 | |||
| JP2013538564A | 2013-10-17 | |||
| JP2011524373A | 2011-09-01 |
Other References:
MOLECULAR IMMUNOLOGY, 2002, VOL.39, PP.323-331, JPN6020041106, ISSN: 0004971972
Attorney, Agent or Firm:
Ryoichi Takaoka
Nao Oda
Akiyo Iwahori
Kamoto Takahashi
Nao Oda
Akiyo Iwahori
Kamoto Takahashi
Previous Patent: Micropump with cam mechanism for axial displacement of rotor
Next Patent: Nucleic acid oligomers and their uses
Next Patent: Nucleic acid oligomers and their uses